Group One Trading, L.P. Genetic Technologies LTD Transaction History

Group One Trading, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$0.0 - $0.0 $0 - $0	-11,208 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$0.0 - $0.01 $0 - $512	-51,200 Reduced 82.04%	11,208 $21,000
Q3 2021 Nov 12, 2021	SELL	$0.0 - $0.01 $0 - $171	-17,102 Reduced 21.51%	62,408 $193,000
Q2 2021 Aug 10, 2021	BUY	$0.0 - $0.02 $0 - $613	30,675 Added 62.81%	79,510 $338,000
Q1 2021 May 12, 2021	BUY	$0.0 - $0.01 $0 - $292	29,265 Added 149.54%	48,835 $204,000

Q4 2020 Feb 10, 2021	BUY	$0.0 - $0.0 $0 - $0	5,370 Added 37.82%	19,570 $70,000
Q3 2020 Nov 12, 2020	BUY	$0.0 - $0.0 $0 - $0	14,200 New	14,200 $49,000

Ticker GENE
Exchange OTC
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 15,389,900
Market Cap $19.1M
Description
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to ...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.